Literature DB >> 18506765

Long-term outcome of childhood acute lymphoblastic leukemia treated in China.

Yongmin Tang1, Xiaojun Xu, Hua Song, Shilong Yang, Shuwen Shi, Jian Wei.   

Abstract

BACKGROUND: To retrospectively determine the treatment outcome and causes of treatment failure of ALL children treated in a single institution at East China. PROCEDURE: Between January 1998 and October 2004, 346 newly diagnosed ALL patients <or=16 years were admitted to our hospital. Of these, 248 patients received modified National Protocol of Childhood ALL in China 1997 (NPCAC97) for at least 2 weeks of treatment and were eligible for protocol evaluation.
RESULTS: Among the 346 newly diagnosed patients, 167 (48.3%) stopped treatment either at diagnosis or during therapy. The abandonment rates for urban area group (UAG) and rural area group (RAG) were 25.3% and 57.3%, respectively (P < 0.0001). The 5-year event-free survival (EFS) rate for the entire cohort was 38.5 +/- 2.7%. For 248 evaluable patients, the remission rate was 97.2%. The 5-year EFS and overall survival (OS) rates were 70.7 +/- 3.6% and 82.1 +/- 3.0%, respectively. The 5-year EFS for standard-risk group (n = 196) was significantly higher than that of high-risk group (n = 52) (75.9 +/- 3.9% vs. 50.7 +/- 8.0%, P = 0.0002). Prognostic factor analysis showed that poor response to remission induction therapy and a poor socioeconomic status were predictive for an inferior outcome.
CONCLUSION: Abandonment of chemotherapy was the most common cause of treatment failure, which was strongly related to poor socioeconomic status and financial support. For patients who could adhere to the treatment protocol, a relatively good outcome was achieved. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18506765     DOI: 10.1002/pbc.21629

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Prognostic significance of the tumor suppressor protein p53 gene in childhood acute lymphoblastic leukemia.

Authors:  Wenwen Weng; Ping Zhang; Jinfei Ruan; Yao Zhang; Diandian Ba; Yongmin Tang
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

2.  Socioeconomic variation in survival from childhood leukaemia in northern England, 1968-2010.

Authors:  K Njoku; N Basta; K D Mann; R J Q McNally; M S Pearce
Journal:  Br J Cancer       Date:  2013-05-07       Impact factor: 7.640

3.  Measuring health-related quality of life in children with cancer living in Mainland China: feasibility, reliability and validity of the Chinese Mandarin version of PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module.

Authors:  Yi Ji; Siyuan Chen; Kai Li; Nong Xiao; Xue Yang; Shan Zheng; Xianmin Xiao
Journal:  Health Qual Life Outcomes       Date:  2011-11-23       Impact factor: 3.186

4.  Magnitude of Treatment Abandonment in Childhood Cancer.

Authors:  Paola Friedrich; Catherine G Lam; Elena Itriago; Rafael Perez; Raul C Ribeiro; Ramandeep S Arora
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

5.  Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate.

Authors:  Shi-Long Yang; Fen-Ying Zhao; Hua Song; Di-Ying Shen; Xiao-Jun Xu
Journal:  ScientificWorldJournal       Date:  2015-06-21

6.  Pediatric Medical Care System in China Has Significantly Reduced Abandonment of Acute Lymphoblastic Leukemia Treatment.

Authors:  Qi Zhou; Dan Hong; Jun Lu; Defei Zheng; Neetica Ashwani; Shaoyan Hu
Journal:  J Pediatr Hematol Oncol       Date:  2015-04       Impact factor: 1.289

7.  Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey.

Authors:  Paola Friedrich; Catherine G Lam; Geetinder Kaur; Elena Itriago; Raul C Ribeiro; Ramandeep S Arora
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

8.  Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran.

Authors:  Hadi Hayati; Abbas Kebriaeezadeh; Mohammad Ali Ehsani; Shekoufeh Nikfar; Ali Akbari Sari; Azim Mehrvar; Elham Shahgholi
Journal:  Iran J Public Health       Date:  2018-03       Impact factor: 1.429

9.  Rs4846049 Polymorphism at the 3'-UTR of MTHFR Gene: Association with Susceptibility to Childhood Acute Lymphoblastic Leukemia.

Authors:  Xiaolei Li; Shunguo Zhang; Feng Yu
Journal:  Biomed Res Int       Date:  2019-10-13       Impact factor: 3.411

Review 10.  Low socioeconomic status is associated with worse survival in children with cancer: a systematic review.

Authors:  Sumit Gupta; Marta Wilejto; Jason D Pole; Astrid Guttmann; Lillian Sung
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.